Torthaí cuardaigh - Barbara Makepeace
- 1 - 1 toradh as 1 á dtaispeáint
-
1
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma de réir Kyaw Lwin Aung, Elaine McWhirter, Stephen Welch, Lisa Wang, Sophia Lovell, Lee-Anne Stayner, Saara Ali, Anne Malpage, Barbara Makepeace, Makilpriya Ramachandran, Gun Ho Jang, Steven Gallinger, Tong Zhang, Tracy Stockley, Sandra E. Fischer, Neesha C. Dhani, David W. Hedley, Jennifer J. Knox, Lillian L. Siu, Rachel Goodwin, Philippe L. Bédard
Foilsithe / Cruthaithe 2022Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Adverse effect
Biology
Cancer
Cell biology
Chemotherapy
Clinical endpoint
Clinical trial
Colorectal cancer
Concomitant
Gastroenterology
Gemcitabine
Internal medicine
KRAS
Kinase
MAPK/ERK pathway
MEK inhibitor
Medicine
Oncology
Phases of clinical research
Progression-free survival
Progressive disease
Response Evaluation Criteria in Solid Tumors
Surgery
Trametinib